990 results on '"*PARVOVIRUS B19"'
Search Results
2. Clinical and historical infection of Tacheng tick virus 2: A retrospective investigation.
- Author
-
Jia, Yuqing, Zhang, Yu, Wu, Xuanchen, Dong, Zhihui, Xie, Songsong, Li, Wei, Liu, Quan, Lu, Xiaobo, and Wang, Yuanzhi
- Subjects
- *
ANAPLASMA phagocytophilum , *PARVOVIRUS B19 , *TICK infestations , *IXODIDAE , *LYME disease , *BIOLOGICAL evolution , *TICKS , *ENZYME-linked immunosorbent assay , *RED fox - Abstract
Background: Tacheng tick virus 2 (TcTV-2) is an emerging tick-borne virus belonging to the genus Uukuvirus in the family Phenuiviridae. Initially isolated in 2019 from a patient in Xinjiang Uygur Autonomous Region (XUAR), northwestern China, who developed fever and headache after a tick bite, TcTV-2 was concurrently molecularly detected in hard ticks across various countries, including China, Kazakhstan, Romania, and Turkey. This study conducted a retrospective epidemiological investigation of TcTV-2 infection. Methodology: In this retrospective cohort study, we collected samples from 47 tick-bitten patients, 984 herdsmen, 7 Asian badgers, 13 red foxes, and 168 Hyalomma asiaticum tick egg batches. Patients' samples were primarily analyzed by using high-throughput sequencing, targeting the V3-V4 region of the bacterial 16S rRNA gene and viral cDNA libraries. Typical tick-borne pathogens were further confirmed using RT-PCR and detected in Asian badgers, red foxes and Hy. asiaticum tick egg batches. We also conducted enzyme-linked immunosorbent assay (ELISA) to detected specific IgM and IgG antibodies against TcTV-2 in herdsmen. Phylogenetic analysis was performed to genetically characterize TcTV-2 detected in this study. Principal findings: TcTV-2 was detected in various samples, including blood, urine, and throat swabs from 12.77% (6/47) tick-bitten patients. It was found in blood samples of 14.29% (1/7) of wild badgers, 7.69% (1/13) of red foxes, and 13.69% (23/168) of Hy. asiaticum egg batches. Furthermore, ELISA results revealed that 9.55% (94/984) of the serum samples (34 from males and 60 from females) were tested positive for TcTV-2-specific IgG, while 2.95% (29/984, 7 males and 22 females) showed positivity for TcTV-2-specific IgM. Additionally, 1.02% (10/984, 4 males and 6 females) of the sera tested positive for both TcTV-2-specific IgM and IgG. Phylogenetic analysis indicated that the TcTV-2 strains detected in this study were genetically similar, regardless of their origin and host species. Conclusions: Clinical symptoms of TcTV-2 infection in patients are nonspecific, with common symptoms including headache, fever, asthenia, vomiting, myalgia, rash, and meningitis-like signs. TcTV-2 can be detected in blood, urine, and throat swab samples of infected patients. Among local herdsmen, 9.55% tested positive for TcTV-2-specific IgG and 2.95% for TcTV-2-specific IgM. Importantly, TcTV-2 can be transovarially transmitted in Hy. asiaticum ticks, and the Asian badgers and red foxes are potential reservoirs of TcTV-2. Author summary: Tacheng tick virus 2 was initially identified in China through a metagenomic analysis of ticks. A patient bitten by a tick was subsequently found to be infected with the virus, suggesting an association with human febrile disease. Subsequent detections of TcTV-2 in various tick species have been reported in Kazakhstan, Romania, Turkey, Poland, Ukraine, and Georgia. However, the infection dynamics of this emerging tick-borne virus in humans and animals remain unclear. In this study, we identified 6 additional patients infected with TcTV-2, presenting with nonspecific clinical symptoms such as fever, asthenia, vomiting, myalgia, rash, and signs resembling meningitis. TcTV-2 was detectable in blood, urine, and throat swabs. Moreover, 9.55% of local herdsmen tested positive for TcTV-2-specific IgG and 2.95% tested positive for specific IgM. We also identified Asian badgers and red foxes as potential animal reservoirs, highlighting that TcTV-2 can be transovarially transmitted in Hyalomma asiaticum ticks. These findings significantly contribute to our understanding of the infection and transmission dynamics of this emerging tick-borne virus. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Decreasing parvovirus B19 and hepatitis A nucleic acid test positivity rates in Canadian plasma donors following the initiation of COVID‐19 restriction in March 2020.
- Author
-
Drews, Steven J., Charlton, Carmen, O'Brien, Sheila F., Burugu, Samantha, and Denomme, Gregory A.
- Subjects
- *
PARVOVIRUS B19 , *NUCLEIC acids , *VIRAL hepatitis , *HEPATITIS viruses , *HEPATITIS A virus - Abstract
Background and Objectives: In Canada, plasma sent for fractionation is tested for both parvovirus B19 (B19V) and hepatitis A virus (HAV). This study compared positivity rates of B19 and HAV nucleic acid tests (NATs) in Canadian plasma samples for the pre‐COVID‐19 restriction era (2015 to end of February 2020 [Q1] 2020) and the post‐COVID‐19 restriction era. Materials and Methods: Pooled EDTA plasma specimens were tested within 24 months of blood draw using the Procleix Panther System (Grifols Diagnostic Solutions Inc, San Diego, CA, USA) for B19V and HAV detection. Reactive pools were resolved by individual specimen testing. Results: Between 1 January 2015, and 31 March 2022, 3,928,619 specimens from Canadian plasma donors were tested for B19V. For the same period, 3,922,954 specimens were tested for HAV. To account for a lag in specimen testing for up to 24 months, the data were divided into: (1) a pre‐pandemic period (1 January 2015–31 March 2020; B19V tested n = 2,412,701, B19V NAT‐positive n = 240 [0.01%], HAV tested n = 2,407,036, HAV NAT‐positive n = 26 [0.001%]); (2) a two‐year mixed‐impact period (1 April 2020–31 March 2022; B19V tested n = 968,250, B19V NAT‐positive n = 14 [0.001%], HAV tested n = 968,250, HAV NAT‐positive n = 2 [0.0002%]); and (3) a pandemic‐impact period (1 April 2022–31 March, 2023; B19V tested n = 597,668, B19V NAT‐positive n = 3 [0.0005%], HAV tested n = 597,668, HAV NAT‐positive n = 1 [0.0002%]). Conclusion: The percentage of B19V‐ and HAV‐positive donations was significantly reduced from the pre‐pandemic period to the pandemic‐impact period. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Seroinfection of Antibodies to Toxoplasma gondii, Parvovirus B19, Treponema pallidum, and HIV in a Pregnant Attending a Medical Center in Northern Peru.
- Author
-
Cubas-Alarcón, Deniss, Guevara-Vásquez, Génesis Masiel, Suclupe-Campos, Danny Omar, Castro-Martínez, Salvadora, Aguilar-Gamboa, Franklin Rómulo, and Failoc-Rojas, Virgilio E.
- Subjects
- *
PARVOVIRUS B19 , *TREPONEMA pallidum , *TOXOPLASMA gondii , *HIV infections , *PREGNANT women - Abstract
Introduction. Transplacental infections are frequent, especially in developing countries, where limited screening is performed to find infectious agents in the pregnant population. We aim to determine the clinical and epidemiological characteristics and seroinfection of antibodies against Toxoplasma, parvovirus B19, T. pallidum, and HIV in pregnant women who attended the Motupe Health Center in Lambayeque, Peru during July-August 2018. Methods. A descriptive cross-sectional study was conducted in 179 pregnant women interviewed with a standardized questionnaire. ELISA was used to determine antibodies to Toxoplasma and parvovirus B19. The detection of syphilis and HIV was conducted using immunochromatography, while the detection of hepatitis B was conducted using FTA-ABS and immunofluorescence, respectively. Results. Of 179 pregnant women, syphilis and HIV infections routinely included in the screening of pregnant women presented a seroinfection of 2.2 and 0.6%, respectively. Toxoplasmosis seroinfection was 25.1%, while IgM antiparvovirus B19 was 40.8%, revealing that pregnant women had an active infection at the time of study. Conclusion. The level of seroinfection of toxoplasmosis reveals the risk to which pregnant women who participated in the study are exposed. The high seroinfection of parvovirus B19 could explain the cases of spontaneous abortion and levels of anemia in newborn that have been reported in Motupe, Lambayeque, Peru. However, future causality studies are necessary to determine the significance of these findings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Distinct clinical features of transplanted children with Parvovirus B19 infection.
- Author
-
Jia, Ran, Cao, Lingfeng, Lu, Lijuan, Zhong, Huaqing, Xu, Menghua, Liu, Pengcheng, Zhu, Xunhua, Su, Liyun, and Xu, Jin
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *HEMATOPOIETIC stem cells , *STEM cell transplantation , *CHILDREN'S hospitals - Abstract
Background: The immature and suppressed immune response makes transplanted children a special susceptible group to Parvovirus B19 (PVB19). However, the clinical features of transplanted children with PVB19 infection haven't been comprehensively described. Methods: We searched the medical records of all the transplant recipients who attended the Children's Hospital of Fudan University from 1 Oct 2020 to 31 May 2023, and reviewed the medical literature for PVB19 infection cases among transplanted children. Results: A total of 10 cases of PVB19 infection were identified in 201 transplanted children at our hospital, and the medical records of each of these cases were shown. Also, we retrieved 40 cases of PVB19 infection among transplanted children from the literature, thus summarizing a total of 50 unique cases of PVB19 infection. The median time to the first positive PVB19 DNA detection was 14 weeks post-transplantation. PVB19 IgM and IgG were detected in merely 26% and 24% of the children, respectively. The incidence of graft loss/dysfunction was as high as 36%. Hematopoietic stem cell transplant (HSCT) recipients showed higher PVB19 load, lower HGB level, greater platelet damage, lower PVB19 IgM/IgG positive rates, and more graft dysfunction than solid-organ transplant (SOT) recipients, indicating a more incompetent immune system. Conclusions: Compared with the published data of transplanted adults, transplanted children displayed distinct clinical features upon PVB19 infection, including lower PVB19 IgM/IgG positive rates, more graft dysfunction, and broader damage on hematopoietic cell lines, which was even more prominent in HSCT recipients, thus should be of greater concern. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Bumps and bacteria: influence of the maternal microbiota on pregnancy outcomes.
- Author
-
Willmott, Thomas and Cottrell, Elizabeth C.
- Subjects
- *
PREGNANCY outcomes , *PREGNANCY complications , *DENITRIFYING bacteria , *GESTATIONAL diabetes , *FETAL development , *PORPHYROMONAS gingivalis , *PARVOVIRUS B19 - Abstract
During pregnancy, all major physiological systems undergo remarkable changes, driven largely by alterations in the maternal hormonal milieu. In healthy pregnancies, maternal cardiovascular and metabolic adaptation to pregnancy occurs to support fetal growth and maternal well-being. Impaired maternal adaptation to pregnancy is associated with a range of pregnancy complications, including gestational diabetes and preeclampsia. There is growing recognition of the importance of different maternal microbiota, including in the gut, vagina and oral cavity, in supporting normal maternal adaptations to pregnancy as well as evidence for microbial disturbances associating with pregnancy pathologies. Here, we aim to summarise emerging evidence demonstrating that differences in maternal microbiota associate with pregnancy outcomes and discuss potential therapeutic approaches under development that might restore an 'optimal' microbiome. In particular, we highlight recent work by ourselves and others exploring the role of the oral microbiome in pregnancy, given established links between poor oral health (e.g. periodontitis) and adverse pregnancy outcomes. Our research has focussed on specific nitrate-reducing oral bacteria which play a role in the generation of nitric oxide (NO) and other bioactive nitrogen oxides associated with cardiovascular health and maternal cardiovascular adaption to pregnancy. Ongoing research aims to define whether altered microbial profiles have clinical utility in the prediction of pregnancy pathologies, and whether interventions designed to optimise specific maternal microbiota could help prevent future complications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. A Multiplex Fluorescence of Loop Primer Upon Self-Dequenching Loop-Mediated Isothermal Amplification Assay for the Detection of Epstein–Barr Virus and Human Parvovirus B19 in Clinical Transplant Samples.
- Author
-
Xu, Yushan, Li, Miaomiao, Lin, Mengjiao, Lv, Yan, Cui, Dawei, Wang, Yongjun, and Xie, Jue
- Subjects
- *
EPSTEIN-Barr virus , *PARVOVIRUS B19 , *FLUORESCENCE , *HEMATOPOIETIC stem cells , *VIRUS diseases , *STEM cell transplantation - Abstract
Viral infections are major causes of mortality in solid-organ and hematopoietic stem cell transplant recipients. Epstein–Barr virus (EBV) and Parvovirus B19 (B19V) are among the common viral infections after transplantation and were recommended for increased screening in relevant guidelines. Therefore, the development of rapid, specific, and cost-effective diagnostic methods for EBV and B19V is of paramount importance. We applied Fluorescence of Loop Primer Upon Self-Dequenching Loop-mediated Isothermal Amplification (FLOS-LAMP) for the first time to develop a novel multiplex assay for the detection of EBV and B19V; the fluorophore attached to the probe are self-quenched in unbound state. After binding to the dumbbell-shaped DNA target, the fluorophore is dequenched, resulting in fluorescence development. The novel multiplex FLOS-LAMP assay was optimized by testing various ratios of primer sets. This novel assay, with great specificity, did not cross-react with the common virus. For the detection of EBV and B19V, the limits of detection could reach 969 and 798 copies/μL, respectively, and the assay could be completed within 25 min. Applying this novel assay to detect 200 clinical transplant individuals indicated that the novel assay had high specificity and good sensitivity. We developed multiplex FLOS-LAMP assay for the detection of EBV and B19V, which has the potential to become an important tool for clinical transplant patient screening. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Changing epidemiology of parvovirus B19 in the Netherlands since 1990, including its re-emergence after the COVID-19 pandemic.
- Author
-
Russcher, Anne, van Boven, Michiel, Benincà, Elisa, Verweij, E. J. T., Molenaar-de Backer, Marijke W. A., Zaaijer, Hans L., Vossen, Ann C. T. M., and Kroes, Aloys C. M.
- Subjects
- *
PARVOVIRUS diseases , *PARVOVIRUS B19 , *HYDROPS fetalis , *COVID-19 pandemic , *PREGNANCY complications , *EPIDEMIOLOGY - Abstract
Parvovirus B19V (B19V) infection during pregnancy can be complicated by potentially life-threatening fetal hydrops, which can be managed by intrauterine transfusion (IUT). This study investigates the long-term temporal patterns in the epidemiology of B19V and evaluates the impact on fetal hydrops, by combining data on B19V infections from the Dutch Sentinel Surveillance system in the period 1990 to 2023, Dutch blood banking data and hospital data on fetal hydrops. Using wavelet analysis, we identified annual epidemic cycles in the Netherlands in the period 1990–2019 and we identified superimposed multiannual cycles in the period 1990–2009. After 2009, no multiannual cycle could be identified, although the incidence fluctuated and correlates with number of IUT performed. As of 2020, weekly reports of B19V infection demonstrated a historically low incidence and B19V-DNA positive blood donors were nearly absent. From May 2020 to May 2023, no IUT for B19V-related hydrops was performed. In the spring of 2023, B19V infections re-emerged, reaching pre-pandemic epidemic levels. Due to the changes in B19V epidemiology over the last 30 years and the near-absence of B19V during the COVID-19 pandemic, the resulting low immunity levels may lead to rebound outbreaks. Alertness to severe complications such as fetal hydrops is warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Detection of Canine Viral and Bacterial Agents Associated with Gastroenteritis by PCR and RT-PCR.
- Author
-
Bhosale, A. V., Tumlam, U. M., Pawade, M. M., Kamdi, B. P., Mhase, P. P., Barate, A. K., and Muglikar, D. M.
- Subjects
- *
ROTAVIRUSES , *CANINE parvovirus , *ESCHERICHIA coli , *GASTROENTERITIS , *PARVOVIRUS B19 , *REVERSE transcriptase polymerase chain reaction , *MIXED infections - Abstract
Background: The important causative agents associated with gastroenteritis include Canine Parvovirus, Canine Rotavirus, Canine coronavirus and E. coli. The diagnostic assay viz. lateral flow test, PCR, RT-PCR was used for screening of diarrheal fecal samples of dogs to detect the presence of these pathogens. Methods: The present study envisaged the appraisal of Canine parvovirus, Rotavirus, corona virus and enterotoxigenic E. coli infection. Total 50 rectal swabs/fecal swab in duplicate were collected for detection of viral andbacterial enteropathogens associated with canine gastroenteritis. For virus detection by PCR a 10% fecal suspension was prepared in phosphate buffer saline (PBS) (pH 7.2). The detection of viral and bacterial agents done by as per reference methods. Result: Out of 50 fecal smples 10(20%) samples were found positive, 2(4%) were found to be positive for Canine Rotavirus and None of sample was found positive for Canine Corona virus. Canine Parvo virus 15(30%) and 1(2%) for Canine rotavirus by PCR and RT-PCR and None of the sample was positive for Canine Corona virus. Of this Canine parvovirus, Rotavirus and E. coli were recovered either singly or in association with each other in the form of mixed infection. Out of 50 samples, 15(30%) and 1(2%) were found positive for Canine parvovirus, Rotavirus and 45(90%) E. coli. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Fetal NT-proBNP levels and their course in severe anemia during intrauterine treatment.
- Author
-
Siebers, Pauline, Gembruch, Ulrich, Merz, Waltraut Maria, Recker, Florian, Müller, Andreas, Strizek, Brigitte, Geipel, Annegret, Berg, Christoph, and Weber, Eva Christin
- Subjects
- *
HYDROPS fetalis , *BRAIN natriuretic factor , *HEART failure , *ANEMIA , *PARVOVIRUS B19 - Abstract
Purpose: In adults and fetuses, N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a marker of cardiac failure and myocardial remodelling. We examined the effect of anemia and intrauterine transfusion (IUT) on NT-proBNP concentrations in fetuses with anemia and established gestational age-dependent reference values of a control group. Methods: We analyzed NT-proBNP levels in anemic fetuses that underwent serial intrauterine transfusions (IUT), focusing on different causes and severity of anemia and comparing the results to a non-anemic control group. Results: In the control group, the average NT-proBNP concentration was 1339 ± 639 pg/ml, decreasing significantly with increasing gestational age (R = − 74.04, T = − 3.65, p = 0.001). Subjects had significantly higher NT-proBNP concentrations before initiation of IUT therapy (p < 0.001), showing fetuses with parvovirus B19 (PVB19) infection having the highest concentrations. Hydropic fetuses also showed an increased NT-proBNP concentration compared to non-hydropic fetuses (p < 0.001). During the course of therapy, NT-proBNP concentration before subsequent IUT decreased significantly from pathologically high levels, while MoM-Hb and MoM-MCA-PSV remained pathological. Conclusion: NT-pro BNP levels in non-anemic fetuses are higher than in postnatal life, decreasing with ongoing pregnancy. Anemia is a hyperdynamic state and its severity correlates with circulating NT-proBNP levels. Highest concentrations occur in fetuses with hydrops and with PVB19 infection, respectively. Treatment by IUT leads to a normalisation of NT-proBNP concentrations, so the measurement of its levels may be useful in therapy monitoring. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. Antiviral alternatives against important members of the subfamily Parvovirinae: a review.
- Author
-
Streck, André Felipe, Lopes, Tamiris Silva, and Lunge, Vagner Ricardo
- Abstract
Parvoviruses are responsible for multiple diseases, and there is a critical need for effective antiviral therapies. Specific antiviral treatments for parvovirus infections are currently lacking, and the available options are mostly supportive and symptomatic. In recent years, significant research efforts have been directed toward understanding the molecular mechanisms of parvovirus replication and identifying potential targets for antiviral interventions. This review highlights the structure, pathogenesis, and treatment options for major viruses of the subfamily Parvovirinae, such as parvovirus B19 (B19V), canine parvovirus type 2 (CPV-2), and porcine parvovirus (PPV) and also describes different approaches in the development of antiviral alternatives against parvovirus, including drug repurposing, serendipity, and computational tools (molecular docking and artificial intelligence) in drug discovery. These advances greatly increase the likelihood of discoveries that will lead to potent antiviral strategies against different parvovirus infections. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. Rubella virus chronic inflammatory disease and other unusual viral phenotypes in inborn errors of immunity.
- Author
-
Kilich, Gonench, Perelygina, Ludmila, and Sullivan, Kathleen E.
- Subjects
- *
RUBELLA virus , *RUBELLA , *VIRUS diseases , *CHRONIC diseases , *HEMOPHAGOCYTIC lymphohistiocytosis , *PARVOVIRUS B19 - Abstract
Summary: Infectious susceptibility is a component of many inborn errors of immunity. Nevertheless, antibiotic use is often used as a surrogate in history taking for infectious susceptibility, thereby disadvantaging patients who present with viral infections as their phenotype. Further complicating clinical evaluations are unusual manifestations of viral infections which may be less familiar that the typical respiratory viral infections. This review covers several unusual viral phenotypes arising in patients with inborn errors of immunity and other settings of immune compromise. In some cases, chronic infections lead to oncogenesis or tumor‐like growths and the conditions and mechanisms of viral‐induced oncogenesis will be described. This review covers enterovirus, rubella, measles, papillomavirus, and parvovirus B19. It does not cover EBV and hemophagocytic lymphohistiocytosis nor lymphomagenesis related to EBV. EBV susceptibility has been recently reviewed. Our goal is to increase awareness of the unusual manifestations of viral infections in patients with IEI and to describe treatment modalities utilized in this setting. Coincidentally, each of the discussed viral infections can have a cutaneous component and figures will serve as a reminder of the physical features of these viruses. Given the high morbidity and mortality, early recognition can only improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Parvovirus B19 Outbreak in Israel: Retrospective Molecular Analysis from 2010 to 2023.
- Author
-
Mor, Orna, Wax, Marina, Arami, Shoshana-Shani, Yitzhaki, Maya, Kriger, Or, Erster, Oran, and Zuckerman, Neta S.
- Subjects
- *
RETROSPECTIVE studies , *PREGNANT women , *YOUNG women , *PARVOVIRUS B19 , *PARVOVIRUSES , *TREND analysis - Abstract
This study presents an analysis of the epidemiological trends of parvovirus B19 (B19V) in Israel from 2010 to 2023, with particular emphasis on the outbreak in 2023. The analysis utilized molecular diagnostic data from individual patients obtained at the Central Virology Laboratory. Between 2010 and 2022, 8.5% of PCR-tested samples were positive for B19V, whereas in 2023, this percentage surged to 31% of PCR-tested samples. Throughout the study period, annual cycles consistently peaked in early spring/summer, with the most recent prominent outbreak occurring in 2016. Predominantly, diagnoses were made in children and women aged 20–39. Despite the notable surge in 2023, over 80% of positive cases continued to be observed in children and young women, with a decrease in cases during winter months. Furthermore, genotype 1a of the virus remained the predominant strain circulating during the outbreak. In light of these circumstances, consideration should be given to implementing screening measures, particularly among high-risk groups such as pregnant women. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Neurocysticercosis: The duration of its preclinical phase relies on the parasite location.
- Author
-
Tellez‐Arellano, Carlos Alejandro, Kuschick‐Fehér, Jan, Romero‐Gonzalez, Franco Gabriel, and Fleury, Agnès
- Subjects
- *
NEUROCYSTICERCOSIS , *ASYMPTOMATIC patients , *BLOOD testing , *PARVOVIRUS B19 , *PARASITES , *THERAPEUTICS , *FISH parasites - Abstract
Objectives: Neurocysticercosis (NC) is a heterogeneous disease particularly in terms of response to treatment and prognosis. Parasite localization is one of the main factors involved in this heterogeneity. In this study we aim to determine whether differences in the duration of the preclinical phase associated with parasite location, could contribute to said heterogeneity. Methods: Ninety‐nine patients were included, 24 with parasites in the parenchyma (PAR), 56 in the subarachnoid (SA) space and 19 in the ventricular system (IV). A questionnaire designed to assess exposure to classic NC risk factors 5, 10, 15, 20 and more than 20 years prior to diagnosis was applied. The results were compared between the three groups. Also, asymptomatic relatives of patients who had shared their living conditions in childhood or more recently were included and underwent brain scan and blood testing for specific antibodies. Results: Over the course of their lives, exposure to risk factors decreased significantly for all patients, although the decrease was more evident in patients with parasites in the SA space (p < 0.001) compared to patients with PAR (p = 0.011) or IV cysts (p = 0.020). Five years prior to diagnosis, exposure to risk factors was significantly higher in patients with PAR or IV NC than in patients with SA NC (p = 0.04). Furthermore, individuals in close contact with PAR or IV patients in the years preceding diagnosis were more likely to have asymptomatic NC, specific antibodies in sera, particularly IgM, compared to individuals in close contact with SA patients during the same period. Conclusions: All these findings are highly suggestive of the possibility of a more recent infection of patients affected by parenchymal and ventricular NC than of patients with subarachnoid NC. Consequently, subarachnoid disease could be considered a chronic disease, which, probably contributes to the severity of the disease as well as the minimal response to medical treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Multiplexed electrical detection of whole viruses from plasma in a microfluidic platform.
- Author
-
Jankelow, Aaron, Chen, Chih-Lin, Cowell, Thomas W., Espinosa de los Monteros, Javier, Bian, Zheng, Kindratenko, Victoria, Koprowski, Katherine, Darsi, Sriya, Han, Hee-Sun, Valera, Enrique, and Bashir, Rashid
- Subjects
- *
PARVOVIRUS B19 , *POINT-of-care testing , *HEPATITIS A virus , *VIRAL hepatitis , *HEPATITIS viruses , *HOSPITAL laboratories - Abstract
The advancement of point-of-care diagnostics is crucial to improving patient outcomes, especially in areas with low access to hospitals or specialized laboratories. In particular, rapid, sensitive, and multiplexed detection of disease biomarkers has great potential to achieve accurate diagnosis and inform high quality care for patients. Our Coulter counting and immunocapture based detection system has previously shown its broad applicability in the detection of cells, proteins, and nucleic acids. This paper expands the capability of the platform by demonstrating multiplexed detection of whole-virus particles using electrically distinguishable hydrogel beads by demonstrating the capability of our platform to achieve simultaneous detection at clinically relevant concentrations of hepatitis A virus (>2 × 103 IU mL−1) and human parvovirus B19 virus like particles (>106 IU mL−1) from plasma samples. The expanded versatility of the differential electrical counting platform allows for more robust and diverse testing capabilities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Parvovirus B19 and Human Parvovirus 4 Encode Similar Proteins in a Reading Frame Overlapping the VP1 Capsid Gene.
- Author
-
Karlin, David G.
- Subjects
- *
PARVOVIRUS B19 , *PHOSPHOLIPASES , *PHOSPHOLIPASE A2 , *PROTEINS , *DNA viruses , *GENES - Abstract
Viruses frequently contain overlapping genes, which encode functionally unrelated proteins from the same DNA or RNA region but in different reading frames. Yet, overlapping genes are often overlooked during genome annotation, in particular in DNA viruses. Here we looked for the presence of overlapping genes likely to encode a functional protein in human parvovirus B19 (genus Erythroparvovirus), using an experimentally validated software, Synplot2. Synplot2 detected an open reading frame, X, conserved in all erythroparvoviruses, which overlaps the VP1 capsid gene and is under highly significant selection pressure. In a related virus, human parvovirus 4 (genus Tetraparvovirus), Synplot2 also detected an open reading frame under highly significant selection pressure, ARF1, which overlaps the VP1 gene and is conserved in all tetraparvoviruses. These findings provide compelling evidence that the X and ARF1 proteins must be expressed and functional. X and ARF1 have the exact same location (they overlap the region of the VP1 gene encoding the phospholipase A2 domain), are both in the same frame (+1) with respect to the VP1 frame, and encode proteins with similar predicted properties, including a central transmembrane region. Further studies will be needed to determine whether they have a common origin and similar function. X and ARF1 are probably translated either from a polycistronic mRNA by a non-canonical mechanism, or from an unmapped monocistronic mRNA. Finally, we also discovered proteins predicted to be expressed from a frame overlapping VP1 in other species related to parvovirus B19: porcine parvovirus 2 (Z protein) and bovine parvovirus 3 (X-like protein). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Seroepidemiology of Human Parvovirus B19 Infection among the Population of Vojvodina, Serbia, over a 16-Year Period (2008–2023).
- Author
-
Vuković, Vladimir, Patić, Aleksandra, Ristić, Mioljub, Kovačević, Gordana, Hrnjaković Cvjetković, Ivana, and Petrović, Vladimir
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *IMMUNOGLOBULINS , *MEDICAL personnel , *BLOOD diseases , *CHILDBEARING age , *IMMUNOGLOBULIN M - Abstract
This study aimed to estimate the serological status and dynamic changes in the prevalence of Parvovirus B19 (PVB19) antibodies within the general population residing in the northern part of the Republic of Serbia (Province of Vojvodina) during a 16-year period. Serum samples were analyzed for Human PVB19-specific IgM and IgG antibodies using enzyme-linked immunosorbent assay (ELISA). Throughout the study period, the overall seroprevalence was 49.51%. Approximately 10% of patients exhibited a serologic profile positive for PVB19 IgM antibodies. Notably, seroprevalence varied significantly, ranging from 9.12% in the pediatric cohort (ages 1–4 years) to 65.50% in the adult demographic (40–59 years old). Seroprevalence was higher (51.88%) among women compared to men (42.50%). Immunologically naive pregnant women in the age groups 26–36 and 36–45 years had 45% (OR = 0.55, 95% CI: 0.31–1.00) and 52% (OR = 0.48; 95% CI: 0.24–0.94) lower odds of having negative IgM and IgG compared to those in age group 16–25 years old. Improved knowledge of the epidemiology of PVB19 may assist clinicians in the differential diagnosis of PVB19 clinical manifestations. The PVB19 detection is particularly important for monitoring individuals in risk groups such as women of reproductive age, medical staff, patients with hematological disorders, and those with immunodeficiency. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Parvovirus B19 Infection and Pregnancy: Review of the Current Knowledge.
- Author
-
Dittmer, Fernanda Parciasepe, Guimarães, Clara de Moura, Peixoto, Alberto Borges, Pontes, Karina Felippe Monezi, Bonasoni, Maria Paola, Tonni, Gabriele, and Araujo Júnior, Edward
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *HYDROPS fetalis , *FETOFETAL transfusion , *VERTICAL transmission (Communicable diseases) , *PATHOGENIC viruses , *ANTIBODY titer - Abstract
Parvovirus B19, a member of the Parvoviridae family, is a human pathogenic virus. It can be transmitted by respiratory secretions, hand-to-mouth contact, blood transfusion, or transplacental transmission. Most patients are asymptomatic or present with mild symptoms such as erythema infectiosum, especially in children. In rare cases, moderate-to-severe symptoms may occur, affecting blood cells and other systems, resulting in anemia, thrombocytopenia, and neutropenia. Non-immune pregnant women are at risk for fetal infection by parvovirus B19, with greater complications if transmission occurs in the first or second trimester. Infected fetuses may not show any abnormalities in most cases, but in more severe cases, there may be severe fetal anemia, hydrops, and even pregnancy loss. Maternal diagnosis of intrauterine parvovirus B19 infection includes IgG and IgM antibody testing. For fetal diagnosis, PCR is performed through amniocentesis. In addition to diagnosing the infection, it is important to monitor the peak of systolic velocity of the middle cerebral artery (PVS-MCA) Doppler to assess the presence of fetal anemia. There is no vaccine for parvovirus B19, and fetal management focuses on detecting moderate/severe anemia by fetal PVS-MCA Doppler, which, if diagnosed, should be treated with intrauterine transfusion by cordocentesis. Prevention focuses on reducing exposure in high-risk populations, particularly pregnant women. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
19. On-column refolding and off-column assembly of parvovirus B19 virus-like particles from bacteria-expressed protein.
- Author
-
Sánchez-Moguel, Ignacio, Coffeen, Carlos Francisco, and Bustos-Jaimes, Ismael
- Subjects
- *
PARVOVIRUS B19 , *CELLULAR recognition , *AFFINITY chromatography , *CELLULAR inclusions , *PROTEINS - Abstract
Virus-like particles (VLPs) are nanometric structures composed of structural components of virions, keeping most of the cellular recognition and internalization properties, but are non-infective as they are deprived of their genetic material. VLPs have been a versatile platform for developing vaccines by carrying their own or heterologous antigenic epitopes. Moreover, VLPs can also be used as nanovessels for encapsulating molecules with therapeutic applications, like enzymes, nucleic acids, and drugs. Parvovirus B19 (B19V) VLPs can be self-assembled in vitro from the denatured major viral particle protein VP2 by equilibrium dialysis. Despite its fair productivity, this process is currently a time-consuming task. Affinity chromatography is used as an efficient step for concentration and purification, but it is only sometimes seen as a method that facilitates the oligomerization of proteins. In this research, we report a novel approach for the in vitro assembly of B19V VLPs through the immobilization of the denatured VP2 into an immobilized metal affinity chromatography (IMAC) column, followed by the on-column folding and the final VLP assembly upon protein elution. This method is suitable for the fast production of B19V VLPs. Key points: • Biotechnological applications for inclusion bodies • Efficient single-step purification and immobilization strategies • Rapid VLP assembly strategy [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Validation of a Parvovirus B19 NAT Assay for Screening of Umbilical Cord Blood for Allogenic Hematopoietic Stem Cell Donation.
- Author
-
Steininger, Philipp, Korn, Klaus, Hackstein, Holger, and Strasser, Erwin F.
- Subjects
- *
PREVENTION of infectious disease transmission , *CELL transplantation , *PARVOVIRUS diseases , *HOMOGRAFTS , *CONFIDENCE intervals , *ACADEMIC medical centers , *RESEARCH methodology , *GOVERNMENT regulation , *MEDICAL screening , *PATIENTS , *CORD blood , *CORDOCENTESIS , *MEDICAL protocols , *DESCRIPTIVE statistics , *HEMATOPOIETIC stem cell transplantation , *SENSITIVITY & specificity (Statistics) , *POLYMERASE chain reaction , *DATA analysis software , *NUCLEIC acid amplification techniques , *TRANSPLANTATION of organs, tissues, etc. - Abstract
Introduction: Parvovirus B19 transmitted by umbilical cord blood (UCB) products may cause severe disease in allogenic hematopoietic stem cell transplant recipients. Thus, commercially available nucleic acid test (NAT) assays for highly sensitive detection of parvovirus B19 DNA validated for the specimen cord blood plasma (CBP) are required to avoid parvovirus B19 transmission by umbilical hematopoietic stem cell preparations. Methods: The multiplex cobas DPX NAT assay was validated for detection of parvovirus B19 DNA in CBP derived from citrate anticoagulated UCB units which have been processed by the Rubinstein method. In total, 363 retained CBP samples pretested negative for parvovirus B19 DNA were prepared for analyzing sensitivity, specificity, and interference of that NAT assay. The 3rd WHO International Standard for parvovirus B19 DNA was used for determining the 95% limit of detection (LOD95) by probit analysis. Results: The validation of the parvovirus B19 NAT assay for CBP demonstrated high sensitivity, specificity, intra- and inter-assay precision. Dilution series and replicate analyses showed a high linearity of the assay with a coefficient of determination above 0.99 and revealed a LOD95 of 17 International Units (IU)/mL (95% confidence interval, 14–44 IU/mL) for parvovirus B19 DNA in CBP samples. Conclusion: The validation of a commercially available parvovirus B19 NAT assay for the specimen CBP demonstrated a high assay performance fulfilling German guidelines and international regulations. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
21. Exploring the Microbial Community Structure in the Chicken House Environment by Metagenomic Analysis.
- Author
-
Lou, Cheng, Chen, Zhuo, Bai, Yu, Chai, Tongjie, Guan, Yuling, and Wu, Bo
- Subjects
- *
CHICKEN coops , *ANIMAL health , *PARTICULATE matter , *METAGENOMICS , *ANIMAL development , *AVIAN influenza A virus , *PARVOVIRUS B19 , *HUMAN-animal relationships , *MICROBIAL communities - Abstract
Simple Summary: Microorganisms suspended in the air are considered one of the main challenges leading to chicken respiratory diseases despite continuous production management and environmental prevention improvements. Traditional feeding modes have some disadvantages, with high density and poor ventilation; therefore, they provide good conditions for microorganisms to survive. The complex composition of microorganisms in the chicken house environment is unknown, especially regarding viruses. However, few works have paid attention to the microbial community structure and its potential risks to animal and human health. The environmental conditions of chicken houses play an important role in the growth and development of these animals. The chicken house is an essential place for the formation of microbial aerosols. Microbial aerosol pollution and transmission can affect human and animal health. In this work, we continuously monitored fine particulate matter (PM2.5) in the chicken house environment for four weeks and studied the microbial community structure in the aerosols of the chicken house environment through metagenomic sequencing. Our results found that bacteria, fungi, viruses, and archaea were the main components of PM2.5 in the chicken house environment, accounting for 89.80%, 1.08%, 2.06%, and 0.49%, respectively. Conditional pathogens are a type of bacteria that poses significant harm to animals themselves and to farm workers. We screened ten common conditional pathogens and found that Staphylococcus had the highest relative abundance, while Clostridium contained the most microbial species, up to 456. Basidiomycetes and Ascomycota in fungi showed dramatic changes in relative abundance, and other indexes showed no significant difference. Virulence factors (VF) are also a class of molecules produced by pathogenic microbes that can cause host diseases. The top five virulence factors were found in four groups: FbpABC, HitABC, colibactin, acinetobactin, and capsule, many of which are used for the iron uptake system. In the PM2.5 samples, eight avian viruses were the most significant discoveries, namely Fowl aviadovirus E, Fowl aviadovirus D, Avian leukosis virus, Avian endogenous retrovirus EAV-HP, Avian dependent parvovirus 1, Fowl adenovus, Fowl aviadovirus B, and Avian sarcoma virus. The above results significantly improve our understanding of the microbial composition of PM2.5 in chicken houses, filling a gap on virus composition; they also indicate a potential threat to poultry and to human health. This work provides an important theoretical basis for animal house environmental monitoring and protection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. Molecular Detection and Sequence Analysis of Chicken Infectious Anemia Virus from Commercial Chicken Flocks in Select Regions of the Philippines.
- Author
-
Del Valle, Fletcher P. and Umali, Dennis V.
- Subjects
- *
CHICKENS , *NUCLEOTIDE sequencing , *SEQUENCE analysis , *PARVOVIRUS B19 , *ANEMIA - Abstract
Background: Chicken infectious anemia virus (CAV) is a ubiquitous pathogen that usually affects young chickens. Clinical infection leads to anemia, lethargy, immunosuppression, and increased mortality. Methods: In this study, 12 Philippine provinces from 5 regions were selected for sampling and testing against CAV using PCR assay. Oropharyngeal-cloacal swabs (OPCs), combined OPCs with tissues, and tissue samples were taken from cooperating breeder, broiler breeder, and layer farms. Results: The overall CAV positivity rate of the collected samples from commercial chicken flocks is 7.26% (34/468). Based on the flock type, a positivity rate of 29.79% (14/47), 11.19% (15/134), and 1.77% (5/282) were detected in layer, breeder, and broiler flocks, respectively. Based on the region, a positivity rate of 1.31% (4/305) and 21.74% (30/138) were detected from Regions III and IVA, respectively. Nucleic acid sequencing and phylogenetic analysis of selected samples showed clustering under genotype D1. Conclusions: The results describe the current CAV situation in commercial chicken flocks from different provinces and their relationship with other strains. Apparently, CAV detection was moderately associated with flock type and region; and weakly associated with flock age and sample type. The local CAV strains from this study were closely related (98.26-99.62%) to Chinese and Taiwanese strains. [ABSTRACT FROM AUTHOR]
- Published
- 2024
23. On-column refolding and off-column assembly of parvovirus B19 virus-like particles from bacteria-expressed protein.
- Author
-
Sánchez-Moguel, Ignacio, Coffeen, Carlos Francisco, and Bustos-Jaimes, Ismael
- Abstract
Virus-like particles (VLPs) are nanometric structures composed of structural components of virions, keeping most of the cellular recognition and internalization properties, but are non-infective as they are deprived of their genetic material. VLPs have been a versatile platform for developing vaccines by carrying their own or heterologous antigenic epitopes. Moreover, VLPs can also be used as nanovessels for encapsulating molecules with therapeutic applications, like enzymes, nucleic acids, and drugs. Parvovirus B19 (B19V) VLPs can be self-assembled in vitro from the denatured major viral particle protein VP2 by equilibrium dialysis. Despite its fair productivity, this process is currently a time-consuming task. Affinity chromatography is used as an efficient step for concentration and purification, but it is only sometimes seen as a method that facilitates the oligomerization of proteins. In this research, we report a novel approach for the in vitro assembly of B19V VLPs through the immobilization of the denatured VP2 into an immobilized metal affinity chromatography (IMAC) column, followed by the on-column folding and the final VLP assembly upon protein elution. This method is suitable for the fast production of B19V VLPs. Key points: • Biotechnological applications for inclusion bodies • Efficient single-step purification and immobilization strategies • Rapid VLP assembly strategy [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Frequency of Human Parvovirus B19 Infection in Pregnancy.
- Author
-
Abd El salam, Basem Gamal, Abd El Hameid, Azza El-Mageid, and El Bakry, Mohammed Abd-Allah
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *HYDROPS fetalis , *PREGNANCY outcomes , *FETAL death - Abstract
Background: Patients with established primary parvovirus infection are at risk of adverse pregnancy outcomes. In addition to the normal checkup for fetal hydrops or intrauterine mortalities, investigation of parvovirus B19 infection was advised. Aim and objectives: The aim of the study is to assess the frequency of parvovirus B19 infection in cases of unexplained intrauterine fetal death, non-immune hydrops, and abortion. Subjects and methods: This study was a cross-sectional study that included 60 female patients who suffered from unexplained intra-uterine fetal death, abortion or, non-immune hydrops during six months. All patients fulfilling the inclusion criteria were recruited from Obstetrics and Gynecology Department of Zagazig University hospitals and Suez Health Insurance Hospital. All participants were subjected to complete history taking with special emphasis on obstetric and prenatal history. Ultrasound examination is performed for all participants to confirm IUFD, abortion or hydrops and to exclude other fetal anomalies not included in our study. We did other investigations including routine laboratory investigations in addition venous blood sampling for detection of human parvovirus B19 antibody IgM and IgG in these samples. Results: The presence of seropositive parvovirus B19 IgG was 43.3% and the presence of 'parvovirus B19 IgM was 5%. Regarding the seropositivity for parvovirus B19 in the studied cases, there was no statistically significant difference between negative and positive groups. Conclusion: The study showed that 48.3% of the women with unexplained intrauterine fetal death, abortion, or nonimmune hydrops were seropositive for HPV B19. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Investigation of Parvovirus B19 Infection Among Iranian Patients with Behcet’s Disease.
- Author
-
Salavatiha, Zahra, Ghorbani, Saied, Saadati, Hassan, Tavakoli, Ahmad, Kiani, Seyed Jalal, Ghasemi, Kimia, and Monavari, Seyed Hamidreza
- Subjects
- *
RESEARCH funding , *ENZYME-linked immunosorbent assay , *POLYMERASE chain reaction , *BEHCET'S disease , *DNA , *DESCRIPTIVE statistics , *CASE-control method , *COMPARATIVE studies , *PARVOVIRUS diseases - Abstract
Background and Aim: Behcet's disease is rare and can cause inflammation in blood vessels throughout the body. Although various studies have been conducted on the possible association between BD and various pathogens such as viruses, the major cause of this disease is still unknown. Our study aimed to evaluate the presence of B19 in Behcet patients and healthy carriers. Materials and Methods: For the current case-control study, we examined 103 samples including 54 males and 49 females, and 40 healthy control samples. At first, all samples were checked by ELISA technique and then, the level of B19 DNA was confirmed by Realtime PCR. Finally, the results of patients were compared to healthy control samples. Results: A wide range of clinical manifestations was observed in the BD patient group. We found statistical differences in the prevalence of B19 IgG between patients and healthy populations (84.46% vs. 55%, respectively). However, the prevalence of B19 IgM was similar between patients and healthy control groups (4.58% vs. 2.5%, respectively). We couldn’t observe any detectable levels of B19 DNA in the patient and healthy carrier groups. Conclusion: Our results failed to establish a relationship between B19 infection and BD development, but such a correlation has been reported. However, there may be an indirect association between genetically susceptible people after a viral infection. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Seroprevalence of Human Parvovirus B19 in Haematological and Extra-haematological Disorders: A Retrospective Observational Study.
- Author
-
SIDDIQUI, TASNEEM, SAHU, CHINMOY, and PATEL, SANGRAM SINGH
- Subjects
- *
PARVOVIRUS B19 , *IMMUNOGLOBULIN M , *MEDICAL sciences , *CONNECTIVE tissues , *ENZYME-linked immunosorbent assay - Abstract
Introduction: Human parvovirus B19 (B19V) has an affinity for multiple organs and causes a myriad of clinical diseases depending on the host’s immunological and haematological status. The seroprevalence of human parvovirus B19 has mostly been studied in haematological disorders, but there is still a lack of data on B19V seroprevalence in extra-haematological disorders. Aim: To study the seroprevalence of B19V in haematological and extra-haematological disorders. Materials and Methods: This retrospective observational study was conducted at the Microbiology Laboratory of Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, Uttar Pradesh, India. Data was collected from September 2017 to September 2020, and data analysis was done from October 2020 to January 2021. A total of 702 serum samples from patients suspected of B19V infection were received over a threeyear duration for parvovirus B19 antibody testing. Of these, 674 serum samples were included in the study as per the inclusion and exclusion criteria. The prevalence of B19V antibodies in different clinical disorders was investigated by collecting patient details like age, gender, underlying clinical disorder, and B19Vspecific Immunoglobulin M (IgM) and IgG antibodies detected by quantitative enzyme immunoassay on all serum samples suspected of B19V infection using Statistical Package for Social Sciences (SPSS) version 25.0 software. The Chi-square test was used to analyse statistically significant variables. Results: B19V-specific IgM and IgG antibodies were detected in 35.7% (241/674) of the serum samples received over a three-year duration. The positivity rate was 94 (13.9%) for IgG, 108 (16%) for IgM, and 39 (5.8%) for both IgG and IgM. The positivity in adults aged 18 years and over (39.6% or 160/404) was statistically significantly higher compared to children aged 17 years and younger (30% or 81/270) (p=0.0109). Among the 241 B19V-positive patients, 126 (52.3%) had haematological disorders, and 115 (47.7%) had extra-haematological disorders. The total positivity of IgG plus IgM antibodies was highest in musculoskeletal and connective tissue disorders (33 (54.1%) and haematological disorders 126 (48.3%). Conclusion: The B19V seroprevalence was relatively low in the present study compared to most serological studies conducted in other regions. The present study provides information on the seroprevalence of B19V in both haematological and extrahaematological disorders simultaneously. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China.
- Author
-
Jiang, Haoran, Qiu, Qi, Zhou, Yangzi, Zhang, Yan, Xu, Wenbo, Cui, Aili, and Li, Xiaomei
- Subjects
- *
PARVOVIRUS B19 , *SYMPTOMS , *GENOMES - Abstract
To understand the epidemiological and genetic characteristics of B19V, a multiple-province surveillance of patients with febrile rash illnesses (FRIs) were conducted in China during 2009 ~ 2021. The clinical specimens of 3,820 FRI patients were collected and tested for B19V DNA. A total of 99 (2.59%) patients were positive for B19V, and 49 (49.49%) were children under 5 years old. B19V infections occurred throughout the year without obvious seasonal pattern. Ten NS1-VP1u sequences and seven genome sequences were obtained in this study, identified as subgenotype 1a. Combined with the globally representative genome sequences, no temporal and geographic clustering trends of B19V were observed, and there was no significant correlation between B19V sequences and clinical manifestations. The evolutionary rate of the B19V genome was 2.30 × 10–4 substitutions/site/year. The number of negative selection sites was higher than that of positive selection sites. It was the first to comprehensively describe the prevalence patterns and evolutionary characteristics of B19V in FRI patients in China. B19V played the role in FRI patients. Children under 5 years old were the main population of B19V infection. Subgenotype 1a was prevalent in FRI patients in China. B19V showed a high mutation rate, while negative selection acted on the genome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Hematological and Extra-Hematological Manifestations of Parvovirus B19 Disease.
- Author
-
Zeybek, Cengiz, Bolat, Ahmet, Gürsel, Orhan, Eker, İbrahim, and Kürekçi, Ahmet Emin
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *ACUTE kidney failure , *HEMOPHAGOCYTIC lymphohistiocytosis , *POLYMERASE chain reaction , *MACROPHAGE activation syndrome - Abstract
Objective Parvovirus B19 (PVB19) is a virus that can present with many hematological and extra-hematological findings. Its prognosis is relatively good in immunocompetent patients, but severe disease may develop in immunocompromised patients. We retrospectively reviewed a series of children who presented with PVB19 during a 6-year period at our institution. Methods Nine children with positive polymerase chain reaction and serological test results for PVB19 were studied. Their demographic data, atypical clinical and laboratory findings, treatment regiments, clinical course, and prognosis were noted. Results The hematological abnormalities associated with PVB19 were anemia, neutropenia, and thrombocytopenia, and the extra-hematological abnormalities were systemic lupus erythematosus-like syndrome, hemophagocytic lymphohistiocytosis, and acute kidney injury. All patients had good outcomes with no significant sequelae. Conclusion This case review suggests that clinicians should not consider PVB19 only as a cause of hematological events; they should also be alert to the possibility that it may cause extra-hematological diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. An Outbreak of Parvovirus B19 in Israel.
- Author
-
Patalon, Tal, Saciuk, Yaki, Trotzky, Daniel, Pachys, Gal, Ben-Tov, Amir, Segal, Yaakov, and Gazit, Sivan
- Subjects
- *
HYDROPS fetalis , *PARVOVIRUS B19 , *ARABS , *ELECTRONIC health records , *SCHOOL children , *POISSON distribution , *PREGNANT women - Abstract
Human parvovirus B19 (B19V) has a wide clinical spectrum, ranging from an asymptomatic infection to a life threatening one. During pregnancy, it can lead to fetal loss and hydrops fetalis. This retrospective study examined the incidence rates of B19V in Israel, analyzing anonymized electronic medical records of 2.7 million individuals between January 2015 and September 2023. A generalized linear model with a Poisson distribution was fit to the data, adjusting for potential confounders. A marked increase in B19V was observed in 2023, with an adjusted incidence rate ratio (IRR) of 6.6 (95% CI 6.33–6.89) when comparing 2023 to previous years. When specifically comparing 2023 to COVID-19 years (2020–2022), adjusted IRR climbs to 9.21 (8.66–9.80). Moreover, in 2023, previously existing seasonality has largely disappeared. High SES characterized most infected individuals with a marked discrepancy in social sectors; the Arab population was significantly less likely to be found B19V positive, even when adjusting for SES. Most infections occurred in school-aged children (6–11 years old). Pregnant women experienced the most significant rise in B19V, with an adjusted IRR of 11.47 (9.44–13.97) in 2023 compared to previous years; most cases were diagnosed in the first trimester. This study demonstrates that Israel is currently experiencing the largest and longest reported outbreak of B19V to date. Policymakers should consider setting screening policies in place, at least for populations at risk, while specifically studying and potentially targeting low socioeconomic populations and specific social sectors to avoid health inequalities. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
30. Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.
- Author
-
Chen, Der-Yuan, Tzang, Chih-Chen, Liu, Chuan-Ming, Chiu, Tsu-Man, Lin, Jhen-Wei, Chuang, Pei-Hua, Kuo, Chia-Wei, Tzang, Bor-Show, and Hsu, Tsai-Ching
- Subjects
- *
SYSTEMIC scleroderma , *PARVOVIRUS B19 , *FIBROSIS , *PARVOVIRUSES , *AUTOIMMUNE diseases , *DNA viruses , *SINGLE-stranded DNA - Abstract
Human parvovirus B19 (B19V) is a single-stranded non-enveloped DNA virus of the family Parvoviridae that has been associated with various autoimmune disorders. Systemic sclerosis (SSc) is an autoimmune connective tissue disorder with high mortality and has been linked to B19V infection. However, the precise mechanism underlying the B19V contribution to the development of SSc remains uncertain. This study investigated the impacts of the functional B19V-VP1 unique region (VP1u) in macrophages and bleomycin (BLE)-induced SSc mice. Cell experimental data showed that significantly decreased viability and migration of both B19V-VP1u-treated U937 and THP-1 macrophages are detected in the presence of celastrol. Significantly increased MMP9 activity and elevated NF-kB, MMP9, IL-6, TNF-α, and IL-1β expressions were detected in both B19V-VP1u-treated U937 and THP-1 macrophages. Conversely, celastrol revealed an inhibitory effect on these molecules. Notably, celastrol intervened in this pathogenic process by suppressing the sPLA2 activity of B19V-VP1u and subsequently reducing the inflammatory response. Notably, the administration of B19V-VP1u exacerbated BLE-induced skin fibrosis in mice, with augmented expressions of TGF-β, IL-6, IL-17A, IL-18, and TNF-α, ultimately leading to α-SMA and collagen I deposits in the dermal regions of BLE-induced SSc mice. Altogether, this study sheds light on parvovirus B19 VP1u linked to scleroderma and aggravated dermal fibrosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
31. Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia.
- Author
-
Staude, Birte, Gschwendtner, Silvia, Frodermann, Tina, Oehmke, Frank, Kohl, Thomas, Kublik, Susanne, Schloter, Michael, and Ehrhardt, Harald
- Subjects
- *
AMNIOTIC liquid , *BRONCHOPULMONARY dysplasia , *PREMATURE labor , *CHORIOAMNIONITIS , *PREMATURE infants , *ENTEROCOCCUS , *PARVOVIRUS B19 - Abstract
Background: Microbiome dysbiosis can have long-lasting effects on our health and induce the development of various diseases. Bronchopulmonary dysplasia (BPD) is a multifactorial disease with pre- and postnatal origins including intra-amniotic infection as main risk factor. Recently, postnatal pathologic lung microbiota colonization was associated with BPD. The objectives of this prospective observational cohort study were to describe differences in bacterial signatures in the amniotic fluid (AF) of intact pregnancies without clinical signs or risk of preterm delivery and AF samples obtained during preterm deliveries and their variations between different BPD disease severity stages. Methods: AF samples were collected under sterile conditions during fetal intervention from intact pregnancies (n = 17) or immediately before preterm delivery < 32 weeks (n = 126). Metabarcoding based approaches were used for the molecular assessment of bacterial 16S rRNA genes to describe bacterial community structure. Results: The absolute amount of 16S rRNA genes was significantly increased in AF of preterm deliveries and detailed profiling revealed a reduced alpha diversity and a significant change in beta diversity with a reduced relative abundance of 16S rRNA genes indicative for Lactobacillus and Acetobacter while Fusobacterium, Pseudomonas, Ureaplasma and Staphylococcus 16S rRNA gene prevailed. Although classification of BPD by disease severity revealed equivalent absolute 16S rRNA gene abundance and alpha and beta diversity in no, mild and moderate/severe BPD groups, for some 16S rRNA genes differences were observed in AF samples. Bacterial signatures of infants with moderate/severe BPD showed predominance of 16S rRNA genes belonging to the Escherichia-Shigella cluster while Ureaplasma and Enterococcus species were enriched in AF samples of infants with mild BPD. Conclusions: Our study identified distinct and diverse intrauterine 16S rRNA gene patterns in preterm infants immediately before birth, differing from the 16S rRNA gene signature of intact pregnancies. The distinct 16S rRNA gene signatures at birth derive from bacteria with varying pathogenicity to the immature lung and are suited to identify preterm infants at risk. Our results emphasize the prenatal impact to the origins of BPD. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
32. Parvovirus B19 Infection May Potentially Determine the Fate of Hematopoiesis by Altering the Human Bone Marrow Mesenchymal Stem Cells Differentiation.
- Author
-
Elmi, Azin, Atashi, Amir, Gheibi, Nematollah, Amiri, Shahin, Ajami, Monireh, Ajami, Mansoureh, Mohammadihaji, Razieh, Khodabandeloo, Naeimeh, and Azad, Mehdi
- Subjects
- *
MESENCHYMAL stem cells , *MESENCHYMAL stem cell differentiation , *PARVOVIRUS B19 , *PARVOVIRUS diseases , *HEMATOPOIESIS - Abstract
Background: Human bone marrow mesenchymal stem cells (hBM -MSCs), as supporters for hematopoiesis, differentiate into osteoblasts and adipocytes. Studies showed that infection of hBM -MSCs by Parvovirus B19 (B19V) can affect the differentiation capability of hBM -MSCs. This study aims to evaluate B19V effects on the differentiation of hBM -MSCs. Materials and Methods: In this experimental study hBM -MSCs were cultured up to passage 3. Nucleofection was subsequently employed to deliver a plasmid containing the B19V genome into the cells. The transfected cells were then differentiated into osteoblast and adipocyte lineages. qRT -PCR was then performed to analyze the differentiation 14 days after transfection. Results: On the 14th day after induction the findings demonstrated a significant increase in adipocyte -specific (PPARγ and LPL) gene expression compared to the control group (p<0.05) and a slight but not statistically significant decrease in the expression of the osteocyte -specific genes (RUNX2 and osteocalcin) (p>0.05). Conclusion: The results suggest that B19V infection can promote the differentiation of hBM -MSCs towards adipocytes and affect the bone marrow microenvironment as well as hematopoiesis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Clinical and immune features of human parvovirus B19 infection in allogeneic stem cell transplantation recipients: A retrospective monocentric study.
- Author
-
Sammut, Rinzine, Feghoul, Linda, Xhaard, Alienor, Dhedin, Nathalie, Robin, Marie, Michonneau, David, Loschi, Michael, Legoff, Jerome, de Peffault de Latour, Regis, and de Sicre de Fontbrune, Flore
- Subjects
- *
STEM cell transplantation , *PARVOVIRUS B19 , *PARVOVIRUS diseases , *PURE red cell aplasia , *HEMATOPOIETIC stem cell transplantation , *MYELITIS - Abstract
Background: Human parvovirus B19 (B19V) infection is associated with pure red cell aplasia (PRCA) in immunocompromised patients; however, the spectrum of manifestations associated with B19V in allogeneic hematopoietic stem cell transplantation recipients (alloHSCT) has rarely been reported. Methods: In this study, we aimed to report clinical and immune features of B19V infection after alloHSCT. We retrospectively collected and analyzed clinical and microbiological data of all transplanted patients with B19V DNAmia or tissue infection detected by polymerase chain reaction (PCR) in our center from 2010 to 2021. Results: We report 35 cases of B19V infections in 33 patients. Median time from transplant to B19V first PCR positivity was 6.9 months (interquartile range (IQR) [1.6–18.9]). No preferential immune profile, type of transplantation or conditioning was identified. Hematological impairment was the most frequent sign, followed by rash and fever. Unconventional clinical forms were also detected, such as acute myelitis and myositis. For some cases, the direct relationship between symptoms and B19V infection was difficult to prove but was suggested by targeted tissue PCR positivity. When hematological impairment was not at the forefront, reticulocytopenia helped to diagnose B19V infections. Treatment was mainly based on high dose intravenous immunoglobulin. Conclusion: Although hematological impairment was the most frequent sign, B19V can affect multiple targets and lead to atypical manifestations. Because of its heterogeneous clinical presentation, B19V infection is likely under‐diagnosed. Diagnosis of unusual B19V organ involvement needs combination of arguments which can include targeted tissue PCR. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
34. Antiviral Treatment of Maternal and Congenital Cytomegalovirus (CMV) Infections.
- Author
-
Pinninti, Swetha and Boppana, Suresh
- Subjects
- *
CYTOMEGALOVIRUSES , *CONGENITAL disorders , *RACE , *VIRUS diseases , *DEMOGRAPHIC characteristics , *PARVOVIRUS B19 , *HUMAN cytomegalovirus - Abstract
Human Cytomegalovirus (HCMV) is a ubiquitous member of the Herpesviridae family, responsible for the most common congenital viral infection—congenital Cytomegalovirus (cCMV) infection. While a majority of HCMV infections in children and adults are asymptomatic, HCMV is well known to cause severe infections in the immunocompromised individual and maternal infections with variable long-term sequelae after maternal–fetal transmission with primary or nonprimary infections. HCMV seroprevalence and cCMV incidence vary by geographic area and demographic characteristics like race and socioeconomic status. While cCMV birth prevalence ranges from 0.2% to 6% in different parts of the world, it is influenced by regional HCMV seroprevalence rates. HCMV screening during pregnancy is not routinely offered due to lack of awareness, hurdles to accurate diagnosis, and lack of well-established effective treatment options during pregnancy. This review will focus on antiviral treatment options currently available for use during pregnancy and in the newborn period for the treatment of maternal and congenital HCMV infections. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China.
- Author
-
Jiang, Haoran, Qiu, Qi, Zhou, Yangzi, Zhang, Yan, Xu, Wenbo, Cui, Aili, and Li, Xiaomei
- Subjects
- *
PARVOVIRUS B19 , *SYMPTOMS , *GENOMES - Abstract
To understand the epidemiological and genetic characteristics of B19V, a multiple-province surveillance of patients with febrile rash illnesses (FRIs) were conducted in China during 2009 ~ 2021. The clinical specimens of 3,820 FRI patients were collected and tested for B19V DNA. A total of 99 (2.59%) patients were positive for B19V, and 49 (49.49%) were children under 5 years old. B19V infections occurred throughout the year without obvious seasonal pattern. Ten NS1-VP1u sequences and seven genome sequences were obtained in this study, identified as subgenotype 1a. Combined with the globally representative genome sequences, no temporal and geographic clustering trends of B19V were observed, and there was no significant correlation between B19V sequences and clinical manifestations. The evolutionary rate of the B19V genome was 2.30 × 10–4 substitutions/site/year. The number of negative selection sites was higher than that of positive selection sites. It was the first to comprehensively describe the prevalence patterns and evolutionary characteristics of B19V in FRI patients in China. B19V played the role in FRI patients. Children under 5 years old were the main population of B19V infection. Subgenotype 1a was prevalent in FRI patients in China. B19V showed a high mutation rate, while negative selection acted on the genome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
36. Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites.
- Author
-
Abuei, Haniyeh, Namdari, Sepide, Pakdel, Tahereh, Pakdel, Fatemeh, Andishe-Tadbir, Azadeh, Behzad-Behbahani, Abbas, Ashraf, Mohammad J., Alavi, Parnian, and Farhadi, Ali
- Subjects
- *
PARVOVIRUS diseases , *CLINICAL pathology , *DNA , *IMMUNOHISTOCHEMISTRY , *CYSTS (Pathology) , *HEAD & neck cancer , *NF-kappa B , *MUCOUS membranes , *CANCER patients , *NASOPHARYNX , *GENE expression profiling , *RESEARCH funding , *COLLECTION & preservation of biological specimens , *POLYMERASE chain reaction , *SQUAMOUS cell carcinoma , *CARRIER proteins , *DISEASE complications - Abstract
Background: The role of human parvovirus B19 (B19V) infection in malignant and benign lesions such as head and neck squamous cell carcinomas (HNSCCs) and oral mucocele lesions has not been established. Herein, we examined, for the first time, the presence of B19V in HNSCCs from Iranian subjects. Methods: One hundred and eight HNSCC specimens were analyzed for the presence of B19V using nested polymerase chain reaction (nPCR) and TaqMan quantitative PCR assays. Immunohistochemistry procedures were performed to evaluate the expression of B19V VP1/VP2 proteins, p16INK4a, and NF-κB in tumor tissues and their adjacent non-tumor tissues. In addition, 40 oral mucocele, 30 oral buccal mucosa swabs, and 30 nasopharyngeal swabs obtained from healthy adults were analyzed as controls. Results: B19V DNA was detected in 36.1% of HNSCCs. Further, 23.3% of HNSCC specimens showed immunoreactivity against B19V VP1/VP2 proteins. There was a significant difference in the frequency of B19V DNA-positive cases between the patient and control groups (p < 0.0001). Moreover, comparing tumoral tissues and their adjacent non-tumor tissues in terms of immunoreactivity against B19V structural proteins, a significant association was found between tumor tissues and B19V infection (p < 0.0001). Finally, investigating the simultaneous presence of B19V and high-risk human papillomaviruses (HPV) DNA, we found a significant association between these two viral infections in HNSCCs (p = 0.031). Conclusions: To sum up, B19V was frequently present in HNSCC tissues of Iranian patients but mostly absent in the adjacent non-tumor tissues as well as oral mucocele lesions, buccal, and nasopharyngeal swabs of healthy subjects. HPV possibly contributes to B19V persistence in HNSCC tissues. Additional research is required to investigate potential etiological or cofactor roles of B19V in the development of HNSCCs. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
37. Abortion and fetal death in sows.
- Author
-
Maes, Dominiek, Peltoniemi, Olli, and Malik, Mateusz
- Subjects
- *
PARVOVIRUS B19 , *FETAL death , *AUJESZKY'S disease virus , *ABORTION , *SWINE influenza , *GENITALIA , *SWINE breeding - Abstract
Abortion in sows or the expulsion of foetuses between days 35 and 109 of gestation results in major financial losses. Abortion is the result of maternal failure due to factors interfering with either the endocrine control of pregnancy or causing endometrial damage. In addition, causes of fetal origin, due to infections with a special affinity for the fetus, can also lead to abortion. Many different non‐infectious and infectious factors may be involved. Non‐infectious risk factors include inappropriate ambient temperature, seasonal effects, different stress factors, and toxic substances. Microorganisms that may cause abortion can be classified as facultative pathogenic and specific pathogenic microorganisms. The first category includes mostly bacteria that are endemic in many pig farms and that are normally harmless commensals. They can cause abortion only in case of decreased immunity or other predisposing factors. Different specific pathogenic microorganisms, especially viruses and bacteria, can cause fetal death and abortion. Some may have a special affinity for the reproductive tract and the foetuses (e.g. Aujeszky's disease virus, parvovirus, Leptospira sp.), while others may cause clinical disease or fever in sows (e.g. swine influenza viruses, Erysipelothrix rhusiopathiae), subsequently leading to abortion. Diagnosis of fetal death and abortion is challenging due to the broad array of processes that may be involved, and the fact that the inciting cause may happen well in advance of the abortion. The diagnostic process should start with a thorough evaluation of the clinical problem and the farm. In case an infectious cause is suspected, proper samples should be collected, preferably from different sows and foetuses, for the detection of specific pathogens. Prevention of abortion mainly relies on the implementation of good management practices, hygiene and biosecurity measures, and for some pathogens also on vaccination. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
38. Molecular Epidemiology of HCV Infection among Multi-Transfused β-Thalassemia Patients in Eastern India: A Six-Year Observation.
- Author
-
Dutta, Supradip, Biswas, Aritra, Bakshi, Sagnik, Choudhury, Promisree, Das, Raina, Nath, Shreyasi, Chowdhury, Prosanto, Bhattacharyya, Maitreyee, Chakraborty, Sharmistha, Dutta, Shanta, and Sadhukhan, Provash Chandra
- Subjects
- *
MOLECULAR epidemiology , *THEILERIA , *PARVOVIRUS B19 , *BLOOD transfusion , *DNA sequencing - Abstract
Background: HCV infection is very common in multi-transfused β-thalassemia patients who need regular blood transfusions. Aim: The study was conducted to determine the epidemiology of HCV in multi-transfused β-thalassemia patients in West Bengal, India. Methods: Over a span of six years, blood samples were collected from HCV sero-reactive β-thalassemia patients and processed for viral RNA isolation followed by nested RT-PCR for qualitative viremia detection. The HCV genotype was determined by amplifying the partial HCV core gene by nested RT-PCR followed by DNA sequencing and NCBI genotyping tools. Phylogenetic and phylogeographic studies were performed with MEGA-X and BEAST software, respectively. Results: Out of 917 multi-transfused HCV sero-reactive β-thalassemia patients, 598 (65.21%) were HCV RNA positive while 250 (41.80%) had spontaneously cleared the virus. A significant percentage of male patients from rural areas (p = 0.042) and economically backward class (p = 0.002) were at higher risk of HCV infection. Female thalassemia patients and individuals belonging to ages 11–15 years had higher chances of spontaneous clearance. The most prevalent circulatory HCV genotype was 3a (78.26%) followed by 1b (12.04%). Phylogeographic analyses revealed that the 3a strains share genomic similarities with strains from Pakistan, Sri Lanka, and Thailand, whereas the 1b strains share similarities with strains from Thailand, Vietnam, Russia, and China. Uncommon HCV subtypes 3g and 3i were also detected. Conclusion: The high prevalence of HCV infection among β-thalassemia patients of West Bengal, India indicates NAT-based assays should be implemented for HCV screening in donor blood to eliminate HCV by 2030. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
39. Relapsing anemia associated with parvovirus B19 infection in a kidney transplant recipient: A case report and review of the literature.
- Author
-
Yaghoubi, Fatemeh, Dalil, Davood, Tavakoli, Farnaz, and Hosseini, Seyyed Mohammad
- Subjects
- *
PARVOVIRUS B19 , *PARVOVIRUS diseases , *LITERATURE reviews , *KIDNEY transplantation , *IRON in the body , *BK virus - Abstract
Key clinical message: PB19 infection should be considered an uncommon cause of posttransplant anemia in renal transplant recipients, particularly those whose anemia is not associated with common etiologies. IVIG treatment and reduced immunosuppression could be beneficial. Parvovirus B19‐associated relapsing anemia is rare in kidney transplant recipients. Herein, we report a case of relapsed anemia due to parvovirus B19 infection in a 53‐year‐old woman 18 months after kidney transplantation. The patient presented with palpitations, shortness of breath, dizziness, weakness, and lethargy. Early laboratory findings showed a WBC count of 6.000/μL, RBC count of 1.89/μL, hemoglobin (Hb) 3.5 g/dL, hematocrit (Hct) 15%, platelet count 266.000/μL, MCV 89, reticulocyte count 0.8%, and serum iron 221 μg/dL. Upon further evaluation, the RT‐PCR test for BK polyomavirus and cytomegalovirus (CMV) was negative, while the parvovirus B19 RT‐PCR was positive. The patient was treated with blood transfusion and IVIG 25 g daily for 5 days. Two months after discharge, the patient presented, complaining of palpitation, shortness of breath, and dizziness, with RBC 2.7/μL, Hb 6.5 g/dL, Hct 25%, and MCV 85. Again, the CMV RT‐PCR was negative, while the parvovirus B19 RT‐PCR was positive. Tacrolimus and mycophenolic acid were stopped, and IVIG 25 g daily for 5 days was administered. Consequently, her Hb level increased to 9 g/dL, and the patient was discharged with prednisolone 5 mg daily and cyclosporine 50 mg daily instead of tacrolimus. Viral infection, particularly PB19 infection, should be considered in the differential diagnosis of posttransplantation anemia in KTRs. IVIG treatment and modification of immunosuppressive medications are suggested standard therapies for such patients. The function of transplanted kidneys should be carefully monitored during treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
40. Liver virome of a Little Corella (Cacatua sanguinea) reveals coinfection with a novel parvovirus and two beak and feather disease viruses.
- Author
-
Sutherland, M and Sarker, S
- Subjects
- *
PSITTACINE beak & feather disease , *PARVOVIRUSES , *PARVOVIRUS B19 , *VIRUS diseases , *MIXED infections , *PATHOGENIC viruses , *CAPPING proteins - Abstract
Emerging diseases are acknowledged as a growing threat to wildlife, with the continued identification of pathogenic and potentially pathogenic viruses in avian species resulting from ongoing advances in molecular diagnostic techniques. Parvoviruses under the genus Chaphamaparvovirus (subfamily Hamaparvovirinae) are highly divergent. The detection and characterisation of parvoviruses in psittacine birds is limited. This study reports a novel parvovirus, tentatively named psittaciform chaphamaparvovirus 3 (PsChV‐3) under the genus Chaphamaparvovirus, identified in an Australian free‐ranging little corella (Cacatua sanguinea). The PsChV‐3 genome is 4277 bp in length and encompasses four predicted open‐reading frames, including two major genes, a nonstructural replicase gene (NS1), and a structural capsid gene (VP1). The NS1 and VP1 genes showed the closest amino acid identities of 78.8% and 69.7%, respectively, with a recently sequenced psittaciform chaphamaparvovirus 2 from Australian Neophema species grass parrots. In addition, the presence of two complete novel beak and feather disease (BFDV) genomes, 1993 and 1868 nt in length, respectively, were detected from the same bird. Both these BFDV genomes contained two bidirectional ORFs encoding the putative Rep and Cap proteins. Phylogenetic analysis showed that the sequenced novel BFDV genomes clustered in a distinct subclade with other BFDVs isolated from Australian cockatoos. This study contributes to the characterisation chaphamaparvoviruses and BFDV in Australian parrots and supports the need for ongoing monitoring and molecular studies into the avian virome in native Australian psittacine bird species. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
41. Comparative Efficacy and Safety of Mycophenolate Mofetil and Azathioprine in Combination with Corticosteroids in the Treatment of Lymphocytic Myocarditis.
- Author
-
Blagova, Olga, Rud', Ruslan, Kogan, Evgeniya, Zaitsev, Alexander, and Nedostup, Alexander
- Subjects
- *
MYCOPHENOLIC acid , *AZATHIOPRINE , *MYOCARDITIS , *SYSTOLIC blood pressure , *PARVOVIRUS B19 - Abstract
Aims: This paper aimed to study the efficacy and safety of mycophenolate mofetil (MM) in combination with corticosteroids in the treatment of lymphocytic myocarditis (LM) when compared to the standard combination of corticosteroids and azathioprine. Methods. The study included 50 adult patients (47.8 ± 10.8 y.o.) in a NYHA III functional class due to LM who were verified using endomyocardial biopsy. The main group included 29 patients who received MM at 2 g/day. The comparison group comprised 21 patients who received azathioprine at 150 [50; 150] mg/day. Both groups were administered with methylprednisolone. The average follow-up period was 30 [22; 35] months, but no less than 6 months. Results. The groups were comparable in the baseline parameters and standard drug therapy. In both groups, there was a comparable significant increase in the ejection fraction (from 30.6 ± 7.7% to 44.0 ± 9.4% vs. 29.2 ± 7.7% to 46.2 ± 11.8%, p < 0.001), and a decrease in systolic pressure in the pulmonary artery and the dimensions of the left ventricle and atrium. The frequency of death was two (6.9%) and two (9.5%), transplantation was one (3.4%) and one (4.8%) patient and the "death + transplantation" endpoint was three (10.3%) and three (14.3%) without differences between the groups. The presence of the parvovirus B19 in the myocardium in 6/5 patients did not affect the results. The incidence of infectious complications was comparable. The most severe infectious complications were pneumonia and fatal purulent encephalitis (both cases in the azathioprine group), leptospirosis meningitis (in the mycophenolate mofetil group). Conclusions. In the patients with LM, the combination of corticosteroids with MM at a dose of 2 g/day was at least no less effective than with azathioprine. There was a tendency toward a better tolerance using MM. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
42. Infection by human polyomaviruses JCPyV and BKPyV in blood donors of Argentina.
- Author
-
Frutos, María C., Blanco, Sebastián, Barahona, Nubia Yandar, Mangeaud, Arnaldo, Carrizo, Luis Horacio, and Gallego, Sandra
- Subjects
- *
POLYOMAVIRUSES , *BLOOD donors , *PARVOVIRUS B19 , *BLOOD transfusion , *BLOOD banks , *POLYMERASE chain reaction - Abstract
Background and Objectives: A spectrum of blood‐borne infectious agents may be transmitted through transfusion of blood components from asymptomatic donors. Despite the persistence of polyomaviruses in blood cells, no studies have been conducted in Argentina to assess the risk of transfusion infection. Materials and Methods: We investigated BKPyV and JCPyV in 720 blood donors, using polymerase chain reaction (PCR) for a region of T antigen common to both viruses. Positive T‐antigen samples were subjected to two additional PCR assays targeting the VP1 region. Viral genotypes were characterized by phylogenetic analysis. Results: Polyomaviruses were detected in 1.25% (9/720) of the blood samples selected; JCPyV was identified in 0.97% (7/720) and BKPyV in 0.28% (2/720) of them. Phylogenetic analysis showed that the JCPyV sequences clustered with 2A genotype and Ia of BKPyV. Conclusion: This study describes for the first time the prevalence of polyomavirus DNA in blood donors of Córdoba, Argentina. The polyomavirus DNAemia in healthy populations suggests that those viruses are present in blood components eligible for transfusion. Therefore, the epidemiological surveillance of polyomavirus in blood banks might be incorporated into haemovigilance programmes, to determine the infectious risk and implement newer interventions to ensure the safety of blood supplies, if required. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
43. Parvovirus B19 Infection: A Vasculitis Masquerade in an Elderly Patient.
- Author
-
Morika Suzuki and Takashi Watari
- Subjects
- *
PARVOVIRUS diseases , *PARVOVIRUS B19 , *OLDER patients , *VASCULITIS , *MICROSCOPIC polyangiitis - Abstract
Objective: Unusual clinical course. Background: The profound ability of viral infections to convincingly mimic vasculitis, thereby pathologically influencing vessels of any caliber, is undeniably significant. Notably, adult patients with B19V infection frequently experience joint pain and cutaneous eruptions, which are ostensibly immune responses to the infection and necessitate careful differentiation from autoimmunity. Conversely, vasculitis syndromes represent an amalgamation of diseases characterized by vascular inflammation, predominantly classified based on the impacted vessels' size and location. Although the expedited diagnosis and therapeutic management of vasculitis are paramount, many conditions, including infectious diseases, can potentially masquerade as vasculitis, necessitating rigorous differential diagnosis. Case Report: A 78-year-old male patient presented with fever, bilateral leg edema, skin rash, and foot numbness to the outpatient department. Blood investigations showed elevated inflammatory parameters, and urinalysis showed proteinuria and occult blood presence. We considered SVV, particularly microscopic polyangiitis, which causes acute renal injury, as the provisional diagnosis. Blood investigations, including auto-antibodies and a skin biopsy, were performed. However, his clinical symptoms resolved spontaneously before these investigation results were reported. Subsequently, the patient was diagnosed with B19V infection based on B19V immunoglobulin M antibody positivity. Conclusions: B19V infection mimics vasculitis. Even in geriatric patients, particularly during B19V infection outbreaks, clinicians should conduct thorough interviews and examinations while contemplating the likelihood of B19V infection as a potential vasculitis mimic. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
44. Eklem yakınmaları olan hastalarda Parvovirus B19 IgG ve IgM seropozitiflik düzeylerinin araştırılması.
- Author
-
HASBEK, Mürşit and ÇUBUK, Fatih
- Subjects
- *
PARVOVIRUS B19 , *HYDROPS fetalis , *HEMOLYTIC anemia , *IMMUNOCOMPROMISED patients , *INFECTION , *MEDICAL microbiology - Abstract
Objective: Parvovirus B19 can cause conditions such as Erythema Infectiosum in children, transient aplastic crises in individuals with chronic hemolytic anemia, permanent anemia in immunosuppressed patients, and hydrops fetalis in pregnant women. Joint complaints may be seen in patients due to primary infection or as a complication of Erythema Infectiosum. The incidence of joint complaints in individuals infected with Parvovirus B19 may vary depending on age. While 8% of infected children have joint complaints; this percentage may increase to 60-80% in adults. On the other hand, it has been reported that information on the prevalence of joint complaints due to viral causes such as Parvovirus B19 is limited and epidemiological data may show regional differences. In our study, it was aimed to investigate the presence of Parvovirus B19 IgG and IgM antibodies in patients admitted to our hospital and to determine the percentages of Parvovirus B19 seropositivity in the patient group with joint complaints. Methods: In the study, Parvovirus B19 IgG and IgM test results obtained from serum samples sent to the Medical Microbiology Laboratory between 2010-2019 were retrospectively analyzed. Results: A total of 679 patients with joint complaints, including 437 women (64.4%) and 242 men (35.6%), were included in this study. Parvovirus B19 IgG test result was positive in 364 (53.6%) of these patients. Parvovirus B19 IgG seropositivity percentage was found to be higher in patients with joint complaints (53.6%) than in patients without joint complaints (38.4%) (p<0.0001). Parvovirus B19 IgG seropositivity percentage was 32.1% in children with joint complaints and 62.3% in adults (p<0.0001). In addition, this percentage was found to be higher in women (58.1%) with joint complaints compared to men (45.5%) (p=0.002). On the other hand, the Parvovirus B19 IgM seropositivity percentage was determined as 3.2% for these patients. This percentage was 1% in children and 4.1% in adults. Conclusion: In particular, the possibility of a primary infection or complication due to Parvovirus B19 should be kept in mind for adult patients with joint complaints. We think that the results of the serological test (IgG-IgM) for Parvovirus B19 in this patient group will contribute to the differential diagnosis. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
45. 重症监护室机械通气患者呼吸机相关性肺炎病原菌分布 及风险预测模型构建.
- Author
-
罗欣悦, 邓 俊, 杨梓苑, 衡 鑫, 张佩芸, and 王宋平
- Subjects
- *
VENTILATOR-associated pneumonia , *INTENSIVE care units , *ARTIFICIAL respiration , *LOGISTIC regression analysis , *GRAM-negative bacteria , *PARVOVIRUS B19 , *KLEBSIELLA pneumoniae - Abstract
Objective: To study the pathogenic distribution of ventilator associated pneumonia (VAP) in patients with mechanical ventilation in intensive care unit (ICU), to analyze its risk factors and build a risk prediction model, so as to provide a theoretical basis for the prevention of VAP. Methods: The clinical data of 137 patients with mechanical ventilation who were admitted to our ICU from December 2018 to June 2021 were retrospectively analyzed. They were divided into 30 cases in the VAP group and 107 cases in the non-VAP group according to whether the occurrence of VAP. The pathogenic distribution of VAP was analyzed, the risk factors of VAP were analyzed by multivariate Logistic regression, and the risk prediction model was built. Results: Among the 30 patients with VAP, 37 strains of pathogenic bacteria were cultured, included 8 strains of Gram-positive bacteria (21.62%), 28 strains of Gram-negative bacteria (75.68%), and 1 strain of fungal strain (2.70%). The occurrence of VAP was associated with chronic respiratory diseases, diabetes mellitus, disturbance of consciousness, tracheotomy, acid-inhibiting drug use, glucocorticoid use, anemia, hypoproteinemia, hospitalization days, mechanical ventilation time, age and other factors (P<0.05). Multivariate Logistic regression analysis showed that hospitalization days>14 d, disturbance of consciousness, glucocorticoid use and age were independent risk factors for the occurrence of VAP (P<0.05). VAP risk prediction model building: PI=1.208× hospital stay>14 d+1.051× disturbance of consciousness +1.012× glucocorticoid use +0.044× age -5.907. In the risk prediction model, the ROC area under curve (AUC) of subjects with VAP in patients with mechanical ventilation in ICU was 0.806. Conclusion: The main pathogens of VAP are Gram-negative bacteria, and the hospitalization days, disturbance of consciousness, glucocorticoid use and age are independent risk factors for the occurrence of VAP. The clinical building risk prediction model is helpful to reduce the incidence of VAP. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
46. Investigation of Parvovirus B19, Cytomegalovirus, Herpes Simplex Virus Types 1 and 2, Human Papillomavirus Types 16 and 18 in Papillary Thyroid Carcinoma.
- Author
-
Kalavari, Fakhriyeh, Tanzifi, Parin, Yousefi, Tahereh, Lotfi, Maryam, and Nazar, Elham
- Subjects
- *
HUMAN herpesvirus 1 , *HUMAN papillomavirus , *PARVOVIRUS B19 , *PAPILLOMAVIRUSES , *PAPILLARY carcinoma , *THYROID cancer , *HERPES simplex virus - Abstract
Background & Objective: Viral infections are associated with the pathogenesis and progression of human malignancies. Several studies have suggested the role of viral infections in papillary thyroid carcinoma (PTC). However, the results are still conflicting, and the potential role of viruses in PTC tumorigenesis remains to be elucidated. In the present study, we aimed to investigate the presence of parvovirus B19, cytomegalovirus (CMV), herpes simplex virus types 1 and 2 (HSV-1/HSV-2), and human papillomavirus (HPV) types 16 and 18 in PTC. Methods: In this cross-sectional study, paraffin-embedded tissue blocks of 40 patients with PTC were used. Tissue blocks were studied for the presence of the virus genome using real-time polymerase chain reaction (PCR). Results: Of the 40 patients with PTC, there was 1 positive case of HPV (2.5%), while 6 cases were positive for parvovirus B19. HSV and CMV DNAs were not detected in any cases. Conclusion: Correlations among HSV, CMV, and PTC are unexpected in our patient population. But parvovirus B19 and, to a lesser extent, HPV DNA genomes were detected in PTC using real-time PCR. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
47. Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.
- Author
-
Kosian, Philipp, Hellmund, Astrid, Geipel, Annegret, Bald, Rainer, Geist, Otilia-Maria, Böckenhoff, Paul, Jimenez-Cruz, Jorge, Deja, Maria, Strizek, Brigitte, Berg, Christoph, and Gembruch, Ulrich
- Subjects
- *
PARVOVIRUS diseases , *PARVOVIRUS B19 , *HYDROPS fetalis , *CORD blood , *ANEMIA , *FETUS - Abstract
Purpose: Evaluating procedure-related complications and perinatal outcomes after intrauterine transfusion (IUT) before or after 20+0 weeks of gestation in fetuses with severe anemia due to intrauterine human parvovirus B19 infection. Methods: A retrospective study investigating fetuses requiring IUT for fetal Parvo B19 infection in two tertiary referral centers between December 2002 and December 2021. Procedure-related complications, intrauterine fetal death (IUFD), and perinatal outcome were correlated to gestational age (GA) at first IUT, the presence of hydrops and fetal blood sampling results. Results: A total of 186 IUTs were performed in 103 fetuses. The median GA at first IUT was 19+3 (13+0–31+4) weeks of gestation. IUFD occurred in 16/103 fetuses (15.5%). Overall survival was 84.5% (87/103). Hydrops (p = 0.001), lower mean hemoglobin at first IUT (p = 0.001) and low platelets (p = 0.002) were strongly associated with IUFD. There was no difference observed in fetuses transfused before or after 20+0 weeks of gestation. Conclusion: IUT is a successful treatment option in fetuses affected by severe anemia due to parvovirus B19 infection in specialized centers. In experienced hands, IUT before 20 weeks is not related to worse perinatal outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
48. Molecular characterisation of the current high prevalence of the new CPV‐2c variants in the Southern Vietnamese dogs signifies a widespread in the worldwide dog population.
- Author
-
Bui, Thi To Nga, Hoang, Minh, Nguyen, Van Dung, Nam Nguyen, Minh, and Than, Van Thai
- Subjects
- *
CANINE parvovirus , *PARVOVIRUSES , *DOGS , *PARVOVIRUS B19 , *VACCINE effectiveness , *GENETIC variation , *MOLECULAR epidemiology , *CIRCOVIRUS diseases - Abstract
Background: Canine parvovirus type 2 (CPV‐2) is known as the primary etiological agent cause of acute gastroenteritis, myocarditis and death of canids worldwide. In Vietnam, although CPV‐2 infection and its outbreaks are the most important risk factors of the canine's health concern, lack of available information about the molecular epidemiology of the CPV‐2. Objectives: In this study, the complete coding sequences of 10 CPV‐2 strains collected from dogs vaccinated with CPV‐2 vaccination were analysed to better understand the genomic characteristics of the current circulating CPV‐2 in Vietnam. Methods: Ten CPV‐specific PCR‐positive rectal swab samples were collected from dogs with acute symptoms of haemorrhagic diarrhoea and vomiting in Vietnam in 2019. The complete coding sequences of these CPV strains were analysed to determine their phylogeny and genetic relationship with other available CPV strains globally. Results: Analysis of the VP2 gene sequences demonstrated that the studied strains belonged to the new CPV‐2c variants with the unique mutations at amino acids 5Ala‐Gly and 447Iso‐Met. Phylogenetic tree analysis indicated that the studied strains share a common evolutionary origin with the current CPV‐2c strains circulating in dogs in Asia countries, including China, Thailand, Taiwan and Mongolia, in recent years. Low sequence identity between the studied strains and commercial vaccine strains was observed. Conclusions: This study provides deep insights into the molecular characteristics, genetic diversity, and evolution of circulating CPV‐2 strains in Vietnam. We recommend more studies to estimate the effectiveness of the CPV vaccine and the need to continue developing other effective vaccination essential to better control the widespread of these new CPV‐2 variants. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
49. Comparison of molecular methods for Bartonella henselae detection in blood donors.
- Author
-
Drummond, Marina Rovani, dos Santos, Luciene Silva, de Almeida, Amanda Roberta, Lins, Karina de Almeida, Barjas-Castro, Maria Lourdes, Diniz, Pedro Paulo Vissotto de Paiva, and Velho, Paulo Eduardo Neves Ferreira
- Subjects
- *
BARTONELLA henselae , *PARVOVIRUS B19 , *BLOOD donors , *CLINICAL pathology , *ERYTHROCYTES , *BACTERIAL DNA , *BLOOD transfusion reaction - Abstract
The Bartonella genus consists of neglected pathogens associated with potentially transfusional-transmitted and fatal human diseases. We aimed to evaluate Bartonella sp. prevalence in 500 blood donors and compare the results with the data already published about these samples. We used molecular diagnostic methods to detect Bartonella sp.-DNA from blood and liquid culture samples: (A) conventional PCR for two gene regions, the ITS targeting the genus Bartonella and the specific gltA Bartonella henselae; (B) nested PCR for the ftsZ gene and (C) qualitative real-time PCR for the gltA gene, both B. henselae specific. We obtained 30/500 (6%) DNA detections from the blood samples; 77/500 (15.4%) DNA detections from liquid culture samples and five (1%) samples had DNA detection from both. In total, we detected B. henselae DNA from 102/500 (20.4%) donors. The samples used in this study had already been submitted for Bartonella sp.-DNA detection using only a conventional PCR in liquid culture. Sixteen samples (3.2%) were positive previously, and from these 16 samples, 13 were negative in the new investigation. We concluded that the use of liquid culture combined with different molecular tests increases the possibility of detecting Bartonella sp.-DNA, but the tests do not avoid false-negative results. More than a fifth of blood donors had at least one PCR that detected Bartonella sp.-DNA among the eight molecular reactions performed now (four reactions in whole blood and four in liquid culture). Seven percent had B. henselae-DNA detection for two or more distinct regions. Considering the results obtained previously, the DNA of Bartonella spp. was detected or the agent isolated in 23% of analyzed blood donors. The results establish that the low bacteremia and the fastidious characteristics of the bacterium are challenges to laboratory diagnosis and can make it difficult to confirm the infection in patients with bartonelloses. Author summary: Bartonella are bacteria that can infect humans and cause fatal diseases. They can cause chronic infection and can potentially be transmitted by transfusion since they infect red blood cells. They are difficult to cultivate in a laboratory, and they are present in low numbers in blood. There is no laboratory test that is sufficiently sensitive to detect them. To compare several laboratory diagnostic tests, we searched for these bacterial DNAs in blood and in microbiological liquid cultures of 500 blood donors. We used diverse molecular techniques and then compared the results with the previously published project. We concluded that the use of liquid culture combined with different molecular tests increases the possibility of detecting Bartonella sp.-DNA, but the tests do not avoid false-negative results. We found Bartonella henselae DNA in the blood of at least one in five donors. Hemovigilance programs are unlikely to contribute substantially to the identification of chronic posttransfusion infections since they are designed to identify well-defined acute outcomes, so it is urgent to review B. henselae transfusional risk of transmission and Bartonella sp. infection diagnosis in donors and in patients. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
50. Pre-Existing Intrarenal Parvovirus B19 Infection May Relate to Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients.
- Author
-
Bertazza Partigiani, Nicola, Negrisolo, Susanna, Carraro, Andrea, Marzenta, Diana, Manaresi, Elisabetta, Gallinella, Giorgio, Barzon, Luisa, and Benetti, Elisa
- Subjects
- *
PARVOVIRUS diseases , *PARVOVIRUS B19 , *GRAFT rejection , *KIDNEY transplantation , *VIRUS diseases , *IMMUNOGLOBULINS - Abstract
Viral infections can lead to transplant dysfunction, and their possible role in rejection is described. In total, 218 protocol biopsies performed in 106 children at 6, 12 and 24 months after transplantation were analyzed according to Banff '15. RT-PCR for cytomegalovirus, Epstein-Barr virus, BK virus and Parvovirus B19 was performed on blood and bioptic samples at the time of transplant and each protocol biopsy. The prevalence of intrarenal viral infection increases between 6 and 12 months after transplantation (24% vs. 44%, p = 0.007). Intrarenal Parvovirus B19 infection is also associated with antibody-mediated rejection (ABMR) (50% ABMR vs. 19% T-cell-mediated rejection, p = 0.04). Moreover, Parvovirus infection is higher at 12 months of follow-up and it decreases at 48 months (40.4% vs. 14%, p = 0.02), while in 24% of grafts, Parvovirus is already detectable at the moment of transplantation. Intrarenal Parvovirus B19 infection seems to be related to ABMR in pediatric kidney recipients. The graft itself may be the way of transmission for Parvovirus, so performance of a PCR test for Parvovirus B19 should be considered to identify high-risk patients. Intrarenal Parvovirus infection presents mainly during the first-year post-transplantation; thus, we recommend an active surveillance of donor-specific antibodies (DSA) in patients with intrarenal Parvovirus B19 infection during this period. Indeed, it should be considered a treatment with intravenous immunoglobulins in patients with intrarenal Parvovirus B19 infection and DSA positivity, even in the absence of ABMR criteria for kidney biopsy. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.